Literature DB >> 28169884

MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension.

Renske Uiterwijk1, Julie Staals, Marjolein Huijts, Peter W de Leeuw, Abraham A Kroon, Robert J van Oostenbrugge.   

Abstract

OBJECTIVE: Hypertension is associated with cognitive deficits, probably because it is a major risk factor for the development of white matter hyperintensities (WMH), lacunes, and cerebral microbleeds, which are MRI markers of cerebral small vessel disease. Studies into associations between presence or progression of these MRI markers and cognitive decline in hypertensive patients are rare. We investigated the association of baseline presence and progression of MRI markers of cerebral small vessel disease with cognitive decline over 4 years in patients with hypertension.
METHODS: In this longitudinal study, hypertensive patients underwent neuropsychological assessments and brain MRI at baseline and after 4 years. Presence and progression of periventricular and subcortical WMH, lacunes, and cerebral microbleeds were visually rated.
RESULTS: In total, 128 hypertensive patients (90 patients with essential hypertension and 38 hypertensive lacunar stroke patients), mean age: 58.6 ± 12.2 years, were included. Progression of periventricular WMH was associated with cognitive decline in simple regression analysis (P = 0.001) and in multivariable analysis with correction for baseline WMH presence and potential confounders (P = 0.004). In this multivariable analysis, R of progression of periventricular WMH was 5.6%, whereas R of baseline presence of periventricular WMH was 0.6%. We did not find significant associations between baseline presence or progression of the other MRI markers and cognitive decline.
CONCLUSION: In patients with hypertension, progression of periventricular WMH over 4 years is associated with cognitive decline, whereas we could not show an association between baseline periventricular WMH and cognitive decline. These results emphasize the importance of preventing progression of WMH in hypertensive patients.

Entities:  

Mesh:

Year:  2017        PMID: 28169884     DOI: 10.1097/HJH.0000000000001294

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

Review 1.  White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.

Authors:  Freddy J Alfaro; Anna Gavrieli; Patricia Saade-Lemus; Vasileios-Arsenios Lioutas; Jagriti Upadhyay; Vera Novak
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

Review 2.  Incident cerebral lacunes: A review.

Authors:  Yifeng Ling; Hugues Chabriat
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-03       Impact factor: 6.200

3.  Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study.

Authors:  Consuelo H Wilkins; Charles C Windon; Peggye Dilworth-Anderson; Justin Romanoff; Constantine Gatsonis; Lucy Hanna; Charles Apgar; Ilana F Gareen; Carl V Hill; Bruce E Hillner; Andrew March; Barry A Siegel; Rachel A Whitmer; Maria C Carrillo; Gil D Rabinovici
Journal:  JAMA Neurol       Date:  2022-10-03       Impact factor: 29.907

Review 4.  Carotid revascularization and cognitive impairment: the neglected role of cerebral small vessel disease.

Authors:  Francesco Arba; Federica Vit; Mascia Nesi; Chiara Rinaldi; Mauro Silvestrini; Domenico Inzitari
Journal:  Neurol Sci       Date:  2021-10-01       Impact factor: 3.830

5.  Remote ischemic conditioning improves cognition in patients with subcortical ischemic vascular dementia.

Authors:  Zhangyuan Liao; Yali Bu; Meijie Li; Ranran Han; Nan Zhang; Junwei Hao; Wei Jiang
Journal:  BMC Neurol       Date:  2019-08-23       Impact factor: 2.474

6.  Plasma brain natriuretic peptide is a biomarker for screening ischemic cerebral small vessel disease in patients with hypertension.

Authors:  Weimin Wei; Yan Chen; Da Lei; Yanan Zhang; Xiuhong Weng; Yuliang Zhou; Li Zhang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  Association between Striatal Brain Iron Deposition, Microbleeds and Cognition 1 Year After a Minor Ischaemic Stroke.

Authors:  Maria Del C Valdés Hernández; Tessa Case; Francesca M Chappell; Andreas Glatz; Stephen Makin; Fergus Doubal; Joanna M Wardlaw
Journal:  Int J Mol Sci       Date:  2019-03-14       Impact factor: 5.923

8.  Increased risk of cognitive impairment and more severe brain lesions in hypertensive compared to non-hypertensive patients with cerebral small vessel disease.

Authors:  Aleksandra M Pavlovic; Tatjana Pekmezovic; Jasna Zidverc Trajkovic; Gordana Tomic; Edita Cvitan; Nada Sternic
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-29       Impact factor: 3.738

Review 9.  Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment.

Authors:  Yang Liu; Yan-Hong Dong; Pei-Yuan Lyu; Wei-Hong Chen; Rui Li
Journal:  Chin Med J (Engl)       Date:  2018-03-05       Impact factor: 2.628

10.  Prevalence and short-term changes of cognitive dysfunction in young ischaemic stroke patients.

Authors:  D Pinter; C Enzinger; T Gattringer; S Eppinger; K Niederkorn; S Horner; S Fandler; M Kneihsl; K Krenn; G Bachmaier; F Fazekas
Journal:  Eur J Neurol       Date:  2019-01-09       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.